Iscador AG, Arlesheim, Switzerland.
Iscador AG, Arlesheim, Switzerland.
Explore linked clinical trials.1 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Iscador® P (Mistletoe) Immunotherapy for Recurrent Resectable Osteogenic Sarcoma | Neoplasm Metastasis, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Connective and Soft Tissue, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, bone disorder, musculoskeletal system disorder, neoplasm, sarcoma | Recruiting | Phase 2 | 2026-05-22 | NCT05726383 |